Zusammenfassung
Die Behandlung von Patienten mit schizophrenen Störungen richtet sich nach klaren, empirisch begründeten Behandlungsprinzipien, die in einer Reihe von Behandlungsleitlinien zugänglich sind (s. unten; Gaebel, in Druck). In Ländern mit einem strukturierten Gesundheitswesen findetsie in einem gegliederten Versorgungssystem statt. Der Psychiater ist hier zwar nicht notwendigerweise die erste Anlaufstelle, wird aber als Spezialist in aller Regel — zumindest bei einer Erstmanifestation konsultiert und leitet — je nach Standort im Versorgungssystem — weitere Behandlungsschritte ein. Im Rahmen einer multiprofessionellen Behandlungsorientierung ist er Letztverantwortlicher für die Aufstellung und Erfüllung eines Gesamtbehandlungsplans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
APA (1997) Practice guideline for the treatment of patients with schizophrenia. APA, Washington
Awad AG (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 43: 262–265
Awad AG (1994) Prediction research of neuroleptic treatment outcome in schizophrenia - State of the art: 1978–1993. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia - concepts and methods. Springer, Wien, pp 1–14
Bachrach LL (1992) Case manage-ment revisited. Hosp Community Psychiatry 43: 209–210
Barnes TRE, Milavic G, Curson DA, Piatt SD (1983) Use of the social behaviour assessment schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine. Soc Psychiatry 18: 193–199
Bellack AS, Mueser KT (1993) Psychosocial treatment of schizophrenia. Schizophr Bull 19:317– 336
Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G (Hrsg) Handbuch der Psychiatrie. Deuticke, Leipzig, S 1–420
Bleuler M, Huber G, Gross G, Schüttler R (1976) Der langfristige Verlauf schizophrener Psychosen. Nervenarzt 47: 477–481
Carpenter WT, Heinrichs DW, Alphs LD (1985) Treatment of negative symptoms. Schizophr Bull 11:440– 452
Coursey RD (1989) Psychotherapy with persons suffering from schizophrenia: the need for a new agenda. Schizophr Bull 15: 349–358
Davis JM (1985) Maintenance therapy and the natural course of schizophrenia. J Clin Psychiatry 11: 18–21
Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6: 70–87
*DGPPN (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde) (1998) Praxis-leitlinien in Psychiatrie und Psychotherapie, Bd 1. Behandlungsleitlinie Schizophrenie. Steinkopff,
Darmstadt Engel GL (1980) The clinical application of the biopsychosocial model. Am J Psychiatry 137: 535–544
Fenton WS, Cole SA (1995) Psychosocial therapies of schizophrenia: individual, group, and family. In: Gabbard GO (ed) Treatments of psychiatric disorders, vol I, 2nd edn. American Psychiatric Press, Washington DC, pp 987–1018
Frances A, Docherty JP, Kahn DA (1996) The expert consensus guideline series. Treatment of schizophrenia. J Clin Psychiatry 57 (Suppl 12B): 1–58
Gaebel W (i993) Tardive Dyskinesien unter Neuroleptika-Behandlung. Dtsch årzteblatt 90:1041–1046
Gaebel W (in Druck) Internationale Leitlinien der Schizophreniebehandlung. In: Müller HJ, Müller N (Hrsg) Behandlung mit atypischen Neuroleptika. Springer, Berlin Heidelberg New York Tokio
Gaebel W, Awad AG (eds) (1994) Prediction of neuroleptic treatment outcome in schizophrenia - concepts and methods. Springer, Wien
Gaebel W, Marder S (1996) Conclusions and treatment recommendations for the acute episode in schizophrenia. Int Clin Psychopharmacol n(Suppl 2 ): 93–100
Gaebel W, Frick U, Kopeke W et al. (1993) Early neuroleptic intervention in schizophrenia: are pro-dromal symptoms valid predictors of relapse? Br J Psychiatry 163 (Suppl 21): 8–12
Goldberg SC (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 11: 453–456
Häfner H, an der Heiden W (1991) Evaluating effectiveness and cost of community care for schizophrenic patients. Schizophr Bull 17: 441–451
Harding CM, Brooks GW, Ashikaga T et al. (1987) The Vermont longitudinal study of persons with severe mental illness. II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 144: 727–735
Helmchen H (1978) Forschungsaufgaben bei psychiatrischer Langzeit-medikation. Nervenarzt 49:534– 538
Hogarty GE, Goldberg SC, Schooler NR, Ulrich RF (1974) Drug and sociotherapy in the aftercare of schizophrenic patients: Two year relapse rates. Arch Gen Psychiatry 31: 603–608
Hogarty GE, Ulrich RF (1977) Temporal effects of drug and placebo in delaying relapse in schizophrenia. Arch Gen Psychiatry 36:585– 590
Janssen B, Burgmann C, Held T et al. (1998) Qualitätsindikatoren der stationären Behandlung schizophrener Patienten. Ergebnisse einer Pilotstudie zur externen Qualitätssicherung mit Hilfe einer Tracer-Diagnose. Psychiatr Prax 25: 303–309
Johnson DAW (1984) Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. J Clin Psychiatry 45: 13–21
Kane JM, Marder SR (1993) Psycho- pharmacologic treatment of schizophrenia. Schizophr Bull 19:87– 302
Kissling W (ed) (1991) Guidelines for relapse prevention in schizophrenia. Springer, Berlin Heidelberg New York Tokio
Kraepelin E (1896) Lehrbuch der Psychiatrie. Barth, Leipzig
Langfeldt G (1937) The prognosis in schizophrenia and the factors influencing the course of the disease. Munksgaard, Copenhagen
Lehman AF, Steinwachs DM, the Survey Co Investigators of the PORT Project (1998a) Translating research into practice: the Schizophrenia Patient Outcomes Re-search Team (PORT) treatment recommendations. Schizophr Bull 24: 1–10
Lehman AF, Steinwachs DM, the Survey Co-Investigators of the PORT Project (1998b) Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull 24: 11–20
Lieberman JA (1993) Prediction of outcome in first-episode schizophrenia. J Clin Psychiatry 54 (Suppl 3): 13–17
Lieberman JA (1994) Predictors of outcome in schizophrenia: the concept of time. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia concepts and methods. Wien, Springer, pp 43– 49
Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DJ, Geisler SH, Szymanski SR (1992) Duration of psychosis and outcome in first episode-schizophrenia. Am J Psychiatry 149: 1183–1188
McGlashan TH (1991) Selective review of recent North American long-term follow-up studies of schizophrenia. In: Mirin SM, Gossett JT, Grob MC (eds) Psychiatric treatment: advances in outcome research. American Psychiatric Press, Washington DC, pp 61–105
McGlashan TH (1994) Psychosocial treatment of schizophrenia. The potential of relationships. In: Andreasen NC (ed) Schizophrenia. From mind to molecule. American Psychiatric Press, Washington DC, pp 189–215
May PRA, Goldberg SC (1978) Prediction of schizophrenic patients’ response to pharmacotherapy. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven, New York, pp 1139–1153
Möller HJ (1994) General aspects of predictor research in schizophrenia and depression. In Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia concepts and methods. Wien, Springer, pp 27–36
Nuechterlein KH (1987) Vulnerability models for schizophrenia: state of the art. In: Häfner H, Janzarik KW, Gattaz W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokio, pp 297–316
Pietzcker A, Gaebel W, Köpke W, Linden M, Müller P, Müller-Spahn F, Tegeler J (1993) Continuous vs intermittent neuroleptic longterm treatment in schizophrenia results of a German multicenter study. J Psychiatr Res 27: 321–339
Rössler W, Löffler W, Fätkenheuer B, Riecher-Rössler A (1992) Does case management reduce the rehospitalization rate? Acta Psychiatr Scand 86: 445–449
Schooler NR (1991) Maintenance medication for schizophrenia: strategies for dose reduction. Schizophr Bull 17: 311–324
Strauss JS, Carpenter WT (1974) The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables. Arch Gen Psychiatry 31: 37–42
Stephens JH (1978) Long-term prognosis and follow-up in schizophrenia. Schizophr Bull 4: 25–48
Tsuang MT, Woolson RF, Fleming JA (1979) Long-term outcome of major psychosis. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch Gen Psychiatry 39: 1295–1301
Van Putten T, May PRA (1978) Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 35: 477–480
Wyatt RJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17: 325–351
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gaebel, W. (2000). Allgemeine Behandlungsprinzipien bei schizophrenen Störungen. In: Helmchen, H., Lauter, H., Henn, F., Sartorius, N. (eds) Psychiatrie der Gegenwart 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59626-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-59626-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64057-5
Online ISBN: 978-3-642-59626-1
eBook Packages: Springer Book Archive